Download PDF
J Pediatr Infect Dis 2023; 18(02): 088-093
DOI: 10.1055/s-0042-1760411
Original Article

Rash and Gastrointestinal Dysfunction May Indicate Cardiac Involvement in Children with Multisystem Inflammatory System Associated with Coronavirus Disease 2019

Ayhan Pektaş
1   Division of Pediatric Cardiology, Department of Pediatrics, Afyonkarahisar Health Sciences University Hospital, Afyonkarahisar, Türkiye
,
Ayşegül Bükülmez
2   Division of Pediatric Gastroenterology, Department of Pediatrics, Afyonkarahisar Health Sciences University Hospital, Afyonkarahisar, Türkiye
,
Mehmet Çeleğen 
3   Division of Pediatric Intensive Care Unit, Department of Pediatrics, Afyonkarahisar Health Sciences University Hospital, Afyonkarahisar, Türkiye
,
İbrahim Eker
4   Division of Pediatric Hematology, Department of Pediatrics, Afyonkarahisar Health Sciences University Hospital, Afyonkarahisar, Türkiye
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective This study aims to investigate the management of children diagnosed with “multisystem inflammatory syndrome” (MIS-C) potentially associated with coronavirus disease 2019 (COVID-19) at a tertiary health center.

Methods This is a retrospective review of 34 children who were diagnosed with MIS-C at the pediatrics department of the study center from August 2021 to December 2021. Data related to age, sex, body mass index, vital findings, laboratory data, clinical symptoms, ultrasonography, and echocardiography findings were acquired from hospital records. Cardiac markers were compared with respect to clinical symptoms and imaging.

Results Fever (91.2%), rash (50%), and abdominal pain (44.1%) were the most observed symptoms. Echocardiography visualized mild mitral regurgitation in 12 patients (35.3%), pericardial effusion in 9 patients (26.5%), and mild coronary dilatation in 9 patients (26.5%). All patients received corticosteroids, whereas acetylsalicylic acid was prescribed in 29 patients (85.3%) and intravenous immunoglobulins were administered in 21 patients (61.8%). Serum probrain natriuretic peptide concentrations were significantly higher in MIS-C patients with rash than those without rash (9,592.2 ± 7,764.5 vs. 1,501.2 ± 1,385.4 pg/mL, p = 0.021). Serum troponin T concentrations were significantly higher in MIS-C patients with ileitis than those without ileitis (0.026 ± 0.024 vs. 0.008 ± 0.003 µg/L, p = 0.013). Serum troponin T concentrations were also significantly higher in MIS-C patients with pericardial effusion than those without pericardial effusion (0.022 ± 0.020 vs. 0.008 ± 0.007 µg/L, p = 0.036).

Conclusion The presence of rash and sonographic visualization of ileitis might act as signs for cardiac involvement in children exposed to COVID-19. To assess the cardiac involvement in MIS-C patients, cardiac enzymes should be measured and echocardiography examination should be performed.

Keywords

child - COVID-19 - inflammation - SARS-CoV-2


Publication History

Received: 31 May 2022

Accepted: 04 December 2022

Article published online:
05 January 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Panaro S, Cattalini M. The spectrum of manifestations of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV2) infection in children: what we can learn from multisystem inflammatory syndrome in children (MIS-C). Front Med (Lausanne) 2021; 8: 747190
    CrossrefPubMedGoogle Scholar
  • 2 Li P, Chen L, Liu Z. et al. Clinical features and short-term outcomes of elderly patients with COVID-19. Int J Infect Dis 2020; 97: 245-250
    CrossrefPubMedGoogle Scholar
  • 3 She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol 2020; 92 (07) 747-754
    CrossrefPubMedGoogle Scholar
  • 4 Posfay-Barbe KM, Wagner N, Gauthey M. et al. COVID-19 in children and the dynamics of infection in families. Pediatrics 2020; 146 (02) e20201576
    CrossrefPubMedGoogle Scholar
  • 5 Williams PCM, Howard-Jones AR, Hsu P. et al. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings. Pathology 2020; 52 (07) 801-808
    CrossrefPubMedGoogle Scholar
  • 6 Verdoni L, Mazza A, Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395 (10239): 1771-1778
    CrossrefPubMedGoogle Scholar
  • 7 Parri N, Lenge M, Buonsenso D. Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with COVID-19 in pediatric emergency departments in Italy. N Engl J Med 2020; 383 (02) 187-190
    CrossrefPubMedGoogle Scholar
  • 8 Martins MM, Prata-Barbosa A, da Cunha AJLA. Update on SARS-CoV-2 infection in children. Paediatr Int Child Health 2021; 41 (01) 56-64
    CrossrefPubMedGoogle Scholar
  • 9 Esposito S, Principi N. Multisystem inflammatory syndrome in children related to SARS-CoV-2. Paediatr Drugs 2021; 23 (02) 119-129
    PubMedGoogle Scholar
  • 10 Henderson LA, Canna SW, Friedman KG. et al. American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: Version 2. Arthritis Rheumatol 2021; 73 (04) e13-e29
    CrossrefPubMedGoogle Scholar
  • 11 Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int 2021; 41 (01) 19-32
    CrossrefPubMedGoogle Scholar
  • 12 Icenogle T. COVID-19: infection or autoimmunity. Front Immunol 2020; 11: 2055
    CrossrefPubMedGoogle Scholar
  • 13 Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel) 2020; 7 (07) 69
    PubMedGoogle Scholar
  • 14 Royal College of Pediatrics and Child Health. Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated With COVID-19. Accessed December 23, 2022 at: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-inflammatorysyndrome-20200501.pdf
    PubMedGoogle Scholar
  • 15 World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Accessed December 23, 2022 at: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatorysyndrome-in-children-andadolescents-with-covid-19
    PubMedGoogle Scholar
  • 16 Huang CY, Chiu NC, Huang FY, Chao YC, Chi H. Prediction of coronary artery aneurysms in children with Kawasaki disease before starting initial treatment. Front Pediatr 2021; 9: 748467
    CrossrefPubMedGoogle Scholar
  • 17 Whittaker E, Bamford A, Kenny J. et al; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324 (03) 259-269
    CrossrefPubMedGoogle Scholar
  • 18 Godfred-Cato S, Bryant B, Leung J. et al; California MIS-C Response Team. COVID-19-associated multisystem inflammatory syndrome in children-United States, March–July 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (32) 1074-1080
    CrossrefPubMedGoogle Scholar
  • 19 Diorio C, Henrickson SE, Vella LA. et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest 2020; 130 (11) 5967-5975
    CrossrefPubMedGoogle Scholar
  • 20 Cattalini M, Della Paolera S, Zunica F. et al; Rheumatology Study Group of the Italian Pediatric Society. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J 2021; 19 (01) 29
    CrossrefPubMedGoogle Scholar
  • 21 Feldstein LR, Tenforde MW, Friedman KG. et al; Overcoming COVID-19 Investigators. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021; 325 (11) 1074-1087
    CrossrefPubMedGoogle Scholar
  • 22 Yakut N, Yuksel E, Algul M. et al. Comparison of clinical and laboratory features in coronavirus disease 2019 and pediatric multisystem inflammatory syndrome patients. Pediatr Int 2022; 64 (01) e14884
    CrossrefPubMedGoogle Scholar
  • 23 Radia T, Williams N, Agrawal P. et al. Multi-system inflammatory syndrome in children and adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev 2021; 38: 51-57
    CrossrefPubMedGoogle Scholar
  • 24 Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr 2021; 180 (07) 2019-2034
    CrossrefPubMedGoogle Scholar
  • 25 Feldstein LR, Rose EB, Horwitz SM. et al; Overcoming COVID-19 Investigators, CDC COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383 (04) 334-346
    CrossrefPubMedGoogle Scholar
  • 26 Dufort EM, Koumans EH, Chow EJ. et al; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020; 383 (04) 347-358
    CrossrefPubMedGoogle Scholar
  • 27 Mercado-Martínez I, Arreaga-Gutiérrez FJ, Pedraza-Peña AN. Intussusception and SARS-CoV-2 infection. J Pediatr Surg Case Rep 2021; 67: 101808
    CrossrefPubMedGoogle Scholar
  • 28 Valitutti F, Verde A, Pepe A. et al. Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era. J Pediatr Surg Case Rep 2021; 69: 101838
    CrossrefPubMedGoogle Scholar
  • 29 Jackson RJ, Chavarria HD, Hacking SM. A case of multisystem inflammatory syndrome in children mimicking acute appendicitis in a COVID-19 pandemic area. Cureus 2020; 12 (09) e10722
    PubMedGoogle Scholar
  • 30 Zhang QY, Xu BW, Du JB. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment. World J Pediatr 2021; 17 (04) 335-340
    CrossrefPubMedGoogle Scholar
  • 31 Ahmed M, Advani S, Moreira A. et al. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine 2020; 26: 100527
    CrossrefPubMedGoogle Scholar
  • 32 Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395 (10237): 1607-1608
    CrossrefPubMedGoogle Scholar
  • 33 Wacker J, Malaspinas I, Vallée JP, Beghetti M. Regression of coronary arteries aneurysms 6 months after multisystem inflammatory syndrome in children (MIS-C). Eur Heart J 2021; 42 (28) 2803
    CrossrefPubMedGoogle Scholar
  • 34 Cherqaoui B, Koné-Paut I, Yager H, Bourgeois FL, Piram M. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review. Rheumatology (Oxford) 2021; 60 (10) 4530-4537
    CrossrefPubMedGoogle Scholar
  • 35 Yeo WS, Ng QX. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. Med Hypotheses 2020; 144: 110263
    CrossrefPubMedGoogle Scholar